CCL5 and metabolic syndrome: Previous studies have shown that polymorphism in the RANTES gene and increased serum levels of RANTES are associated with the incidence of T2D, metabolic syndrome, and coronary artery disease, which are known to be induced by insulin resistance [14,15,16].